View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Sponsored by AIM

Launching a First Product in Europe: The Supply Chain Perspective

Free White Paper

Launching a First Product in Europe: The Supply Chain Perspective

By AIM

Launching a First Product in Europe: The Supply Chain Perspective

By AIM
Enter your details to receive the free paper:

Recently, AIM hosted a webinar panel discussion that addressed the key supply chain aspects associated with launching a new pharmaceutical or biotech therapy in Europe.

Our panel of experts included representatives from AIM as well as the Head of Finance, Europe for Travere Therapeutics.  The key topics of discussion were:

  • • The major steps involved in designing and implementing a life science supply chain in Europe
  • • Supply chain best practices for launch
  • • Most common supply chain “pitfalls” or mistakes when preparing for launch
  • • Timing of major preparations
  • • In-sourcing vs. outsourcing
  • • Key tax and financial issues
  • • Major regulatory, licensing, and legal requirements
  • This paper provides a written summary of the webinar.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU